Skip to main content

Breadcrumb

  1. Home

Highly Prevalent Conditions

Persistence of Beta-Blocker Treatment After a Heart Attack

  • The percentage of patient’s 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who received persistent beta-blocker treatment for six months after discharge.

    CBE ID
    0071

Pharmacotherapy Management of COPD Exacerbation

  • This measure assesses the percentage of COPD exacerbations for patients 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1-November 30 of the measurement year and who were dispensed appropriate medications. Two rates are reported:
    1. Dispensed a systemic corticosteroid (or there was evidence of an active prescription) within 14 days of the event.
    2. Dispensed a bronchodilator (or there was evidence of an active prescription) within 30 days of the event.

    CBE ID
    2856

Pneumonia Mortality Rate (IQI #20)

  • In-hospital deaths per 1,000 hospital discharges with pneumonia as a principal diagnosis for patients ages 18 years and older. Excludes obstetric discharges and transfers to another hospital.

    [NOTE: The software provides the rate per hospital discharge. However, common practice reports the measure as per 1,000 discharges. The user must multiply the rate obtained from the software by 1,000 to report in-hospital deaths per 1,000 hospital discharges.]

    CBE ID
    0231

Postoperative Respiratory Failure Rate (PSI 11)

  • Postoperative respiratory failure (secondary diagnosis), prolonged mechanical ventilation, or reintubation cases per 1,000 elective surgical discharges for patients ages 18 years and older.

    CBE ID
    0533

Postoperative Stroke or Death in Asymptomatic Patients undergoing Carotid Artery Stenting (CAS)

  • Percentage of patients 18 years of age or older without carotid territory neurologic or retinal symptoms within 120 days immediately proceeding carotid angioplasty and stent (CAS) placement who experience stroke or death during their hospitalization for this procedure. This measure is proposed for both hospitals and individual interventionalists. This measure is currently reported by the Vascular Quality Initiative (VQI) Registry.

    CBE ID
    1543

Postoperative Stroke or Death in Asymptomatic Patients undergoing Carotid Endarterectomy

  • Percentage of patients age 18 or older without carotid territory neurologic or retinal symptoms within the one year immediately preceding carotid endarterectomy (CEA) who experience stroke or death following surgery while in the hospital. This measure is proposed for both hospitals and individual surgeons. This measure is presently reported by the Vascular Quality Initiative (VQI) registry.

    CBE ID
    1540

Prenatal Immunization Status

  • Percentage of deliveries in the measurement period in which women received influenza and tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccinations.

    CBE ID
    3484

Preoperative Beta Blockade

  • Percent of patients aged 18 years and older undergoing isolated CABG who received beta blockers within 24 hours preceding surgery.

    CBE ID
    0127

Prescription or administration of pharmacotherapy to treat opioid use disorder (OUD)

  • This measure reports the percentage of a provider’s patients who were Medicaid beneficiaries ages 18 to 64 with an OUD diagnosis who filled a prescription for, or were administered or ordered, a FDA-approved medication to treat OUD within 30 days of the first attributable OUD treatment encounter with that provider.

    CBE ID
    3589